Comparisons of Effects on Intestinal Short-Chain Fatty Acid Concentration after Exposure of Two Glycosidase Inhibitors in Mice.

@article{Xu2018ComparisonsOE,
  title={Comparisons of Effects on Intestinal Short-Chain Fatty Acid Concentration after Exposure of Two Glycosidase Inhibitors in Mice.},
  author={Guo-dong Xu and L. Cai and Yi-shu Ni and Shiyi Tian and Ying-Qi Lu and L. Wang and Lian-Lian Chen and W. Ma and S. Deng},
  journal={Biological & pharmaceutical bulletin},
  year={2018},
  volume={41 7},
  pages={
          1024-1033
        }
}
  • Guo-dong Xu, L. Cai, +6 authors S. Deng
  • Published 2018
  • Chemistry, Medicine
  • Biological & pharmaceutical bulletin
  • Acarbose and voglibose are the most widely used diabetes drugs as glycosidase inhibitors. In this study, the use of these two inhibitors significantly increased the content of starch in large intestine, and altered the concentration of short-chain fatty acids (SCFAs) by affecting the intestinal microbiota. However, there are some differences in the intestinal microbiome of the two groups of mice, mainly in bacteria such as Bacteroidaceae bacteroides and Desulfovibrionaceae desulfovibrio. The… CONTINUE READING
    6 Citations

    References

    SHOWING 1-10 OF 56 REFERENCES
    Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices.
    • 56
    Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health?
    • 289
    • PDF
    Expression of short-chain fatty acid receptor GPR41 in the human colon.
    • 231
    • PDF